The prevalence of CYP2D6*10 (100C>T, rs1065852) gene polymorphism in Russian patients with epilepsy (North-Western and Siberian Districts)
The gene CYP2D6 is of great interest also due to its highly polymorphic nature and involvement in a high number of medication metabolisms. The presence of polymorphisms in the CYP2D6 gene may modulate enzyme level and activity, thereby affecting individual responses to pharmacological treatment. Th...
Saved in:
| Main Authors: | N. A. Sivakova, N. A. Shnayder, D. V. Dmitrenko, L. V. Lipatova, M. Y. Tolmachev, R. F. Nasyrova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-12-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/319 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYP2D6 polymorphism rs1065852 significantly increases the risk of type 2 diabetes
by: Huiyi Wei, et al.
Published: (2025-12-01) -
Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder
by: Masakazu Hatano, et al.
Published: (2025-03-01) -
Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
by: L. N. Lyubchenko, et al.
Published: (2017-10-01) -
Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment Outcomes
by: Lauren Varney, et al.
Published: (2025-06-01) -
CYP2D6-GENOTYPING IN THE ASSESSMENT OF THE EFFECTIVENESS OF THERAPY WITH TAMOXIFEN IN PATIENTS WITH ADVANCED HORMONE RECEPTOR-POSITIVE BREAST CANCER
by: L. N. Lyubchenko, et al.
Published: (2017-12-01)